Surrogacy (Gestational Carrier) — Cost, Top Hospitals & Success Rates | MyMedicPlus

Surrogacy is an arrangement in which a woman (the surrogate or gestational carrier) carries and delivers a pregnancy for another person or couple (the intended parents). Two types exist: gestational surrogacy—the most common form—in which an embryo created through IVF from the intended parents' or donors' gametes is transferred to the surrogate's uterus, so the surrogate has no genetic connection to the child; and traditional surrogacy, in which the surrogate's own egg is used (creating a genetic relationship), which is legally complex and now rarely practiced.

Gestational surrogacy requires a complete IVF cycle: ovarian stimulation and egg retrieval from the intended mother or egg donor, fertilization with the intended father's or donor sperm, embryo culture to blastocyst stage, and endometrial preparation of the surrogate with estrogen and progesterone before embryo transfer. The surrogate carries the pregnancy to term, delivering the child for the intended parents.

Legal status of surrogacy varies enormously internationally. Commercial surrogacy (surrogate receives compensation beyond medical expenses) is permitted in the United States, Ukraine, Georgia, and select other countries. Altruistic surrogacy (no payment beyond expenses) is legal in Canada, the UK, Australia, and New Zealand. Surrogacy is prohibited outright in Germany, France, Spain, Italy, and many other nations. India enacted the Surrogacy (Regulation) Act 2021, permitting only altruistic surrogacy involving a close relative, and banning commercial surrogacy and international surrogacy entirely—a major change from India's prior status as a global surrogacy destination. Intended parents must research current legal frameworks thoroughly in both the destination and home countries before proceeding.

Surrogacy is indicated for individuals and couples for whom carrying a pregnancy is medically impossible, life-threateningly dangerous, or legally or biologically unavailable. The most common medical indication is absent or non-functional uterus: Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome (congenital absence of the uterus, affecting approximately 1 in 4,500 females), hysterectomy performed for cancer, fibroids, or other conditions, and severe Asherman syndrome (intrauterine adhesions) that cannot be surgically corrected.

Medically contraindicated pregnancy is another primary indication: severe cardiac disease (Eisenmenger syndrome, pulmonary arterial hypertension, peripartum cardiomyopathy), advanced renal failure, organ transplant requiring teratogenic immunosuppression, active systemic lupus erythematosus with high-risk features, and prior uterine rupture all represent conditions where pregnancy poses an unacceptable maternal risk, making surrogacy the only safe path to parenthood.

Recurrent implantation failure (RIF)—defined as failure of three or more high-quality blastocyst transfers despite thorough evaluation and treatment—may indicate uterine factor infertility amenable to gestational surrogacy. Recurrent pregnancy loss with a confirmed uterine etiology is another indication. Male same-sex couples and single men require a gestational carrier and egg donor to have biologically related children; this is one of the most rapidly growing indications for surrogacy in countries where it is legally permitted. Single women unable to safely carry pregnancy also utilize surrogacy. In all cases, thorough psychological evaluation, legal counseling, and ethical review are required before proceeding.

Eligibility criteria apply separately to intended parents and to the surrogate. Intended parents must demonstrate either a confirmed inability or medical contraindication to carry pregnancy (supported by specialist medical letters), or inability to produce gametes without donor assistance, or both. Comprehensive fertility workup—including uterine evaluation where applicable—confirms the indication. Psychological counseling explores motivations, expectations, and understanding of the process.

Surrogate eligibility criteria are rigorous. Most agencies and clinics require surrogates to be 21–40 years of age (range varies by jurisdiction and clinic), to have completed their own family with at least one successful previous pregnancy and delivery, to have a healthy BMI (typically 18–30), to be non-smokers, to have no major medical or psychiatric conditions, and to be free of infectious diseases (HIV, hepatitis, CMV, STIs). A thorough psychological evaluation—including standardized psychological testing—of the surrogate and her partner or support person is mandatory. Independent legal representation for both intended parents and surrogate is required before any embryo transfer proceeds.

The surrogate's uterine cavity is evaluated by saline infusion sonography or hysteroscopy before embryo transfer. A mock embryo transfer cycle is performed to assess endometrial response to estrogen-progesterone preparation and optimal transfer technique. Infectious disease screening, complete blood count, thyroid function, and uterine anatomy assessment are completed. Legal contracts documenting compensation (if applicable), parentage, decisions about selective reduction or termination, and post-delivery arrangements must be finalized and reviewed by independent attorneys before the embryo transfer proceeds.

Gestational surrogacy (most common in contemporary practice): the surrogate has no genetic relationship to the child. The intended mother or egg donor undergoes ovarian stimulation and egg retrieval; eggs are fertilised with the intended father's or donor sperm via ICSI; resulting embryos are transferred to the surrogate's uterus in a synchronised or FET cycle. The surrogate's endometrium is prepared with oestrogen followed by progesterone. Single embryo transfer is strongly recommended in surrogacy to minimise obstetric complications in a third-party carrier.

Traditional surrogacy (rare): the surrogate provides her own egg, inseminated with the intended father's sperm — the surrogate is the biological mother, creating complex legal and emotional entanglements. Traditional surrogacy is prohibited or severely restricted in most jurisdictions.

International surrogacy: altruistic surrogacy (UK, Canada, Australia, New Zealand) is legal where no commercial payment is made; compensated commercial surrogacy is legal in specific jurisdictions including parts of the United States (California, Nevada), Georgia, Ukraine (for married heterosexual couples), and Russia. Medical standards, legal protections, and ethical frameworks vary substantially by jurisdiction — legal consultation is essential before entering any international surrogacy arrangement. Surrogacy agency coordination manages surrogate matching, medical synchronisation, legal contract drafting, and post-birth parentage order processes. Shared decision-making between patient and specialist, guided by current evidence-based clinical guidelines and the patient's individual anatomy, comorbidities, and treatment goals, is essential for selecting the most appropriate treatment modality. Pre-treatment specialist consultation, review of relevant investigations, and multidisciplinary input for complex presentations ensure the best possible outcomes.

Gestational surrogacy is the only method by which certain individuals can have genetically related children—those with absent or non-functional uteri, those for whom pregnancy is life-threatening, and male same-sex couples or single men. For these groups, surrogacy transforms what would otherwise be an impossible aspiration into a realistic family-building pathway. The genetic connection to the child—through either the intended parent's eggs or sperm, or both—is preserved in most gestational surrogacy arrangements.

Success rates in gestational surrogacy are generally favorable because the surrogate is typically young, healthy, and has a proven uterus (prior successful pregnancies). Live birth rates per embryo transfer in well-managed programs are 45–55% using fresh or frozen blastocysts from young intended mothers or egg donors. Surrogates typically have optimal endometrial receptivity without the physiological compromise of infertility, ovarian stimulation, or repeated IVF attempts that affect the intended mother's uterus.

Longitudinal research on children born through surrogacy consistently demonstrates healthy psychological development, positive family relationships, and comparable outcomes to children born through other means of assisted reproduction. Intended parents report high satisfaction and positive attachment. Appropriately contracted surrogacy programs with full legal protection provide intended parents confidence in parentage establishment from birth, eliminating post-delivery legal uncertainty. When combined with preimplantation genetic testing (PGT-A) of embryos, gestational surrogacy also reduces miscarriage risk and improves single-transfer live birth rates in programs serving older intended mothers or those with prior recurrent loss.

Medical risks in gestational surrogacy primarily affect the surrogate and the egg donor separately. The egg donor undergoes ovarian stimulation with standard IVF risks: OHSS (mild-moderate in 10–20%, severe in 1–3%), oocyte retrieval complications (bleeding, infection, anesthetic events), and the emotional experience of the donation process. The surrogate faces standard pregnancy risks: gestational diabetes, hypertension, preeclampsia, placenta previa, cesarean delivery, postpartum hemorrhage—the same risks as any pregnancy carried by that individual. Miscarriage rates from embryo transfer are 10–20%, age- and embryo quality-dependent. Multiple pregnancy risk is present if more than one embryo is transferred, increasing maternal and neonatal complications; single embryo transfer is strongly recommended.

Legal risks are substantial and country-specific. International surrogacy carries the risk that the child's citizenship and parentage may not be automatically recognized in the intended parents' home country. Several high-profile cases have resulted in stateless children or custody disputes when countries refused to recognize overseas surrogacy arrangements. Legal pre-clearance in the home country is strongly advised before initiating international surrogacy. If the surrogate changes her mind, laws vary enormously: in some US states, the pre-birth order legally establishes intended parentage before delivery; in other jurisdictions, the birth mother retains legal rights until formal adoption.

Ethical concerns about exploitation, commodification of reproduction, informed consent, and power imbalances between intended parents and surrogates—particularly in commercial arrangements—are actively debated in bioethics and require ongoing attention. Financial unpredictability is high: medical complications, failed cycles, and legal complications can substantially increase total costs beyond initial estimates. Intended parents must have robust financial reserves and contingency planning.

Following embryo transfer, the surrogate undergoes the standard IVF post-transfer protocol: progesterone supplementation, beta-hCG at 12–14 days, and transvaginal ultrasound at 6–7 weeks. Oestrogen and progesterone support continue until 10–12 weeks of gestation. The surrogate receives antenatal care from her own obstetric team, with the intended parents involved according to the agreed arrangement.

Legal parentage: in most jurisdictions, the surrogate (and her spouse/partner, if married) is the legal mother at birth regardless of genetic relationship. Intended parents must obtain a parentage order or court declaration before or after birth to establish legal parenthood — timelines vary by jurisdiction (pre-birth orders available in California; post-birth orders required in UK). International surrogacy requires both the surrogacy country's and the intended parents' home country's legal processes to be completed before the child can travel home. Psychological support for both the surrogate and intended parents throughout the surrogacy journey is strongly recommended, including post-birth counselling as the surrogacy relationship transitions.

Surrogacy is among the most expensive family-building options globally, and total costs vary enormously by country, surrogacy model (commercial vs. altruistic), and the number of IVF cycles required. In the United States, the most legally regulated and transparent commercial surrogacy market, total costs range from $100,000–$200,000. This includes surrogate compensation ($30,000–$60,000), legal fees ($15,000–$25,000), agency fees ($20,000–$35,000), medical costs for IVF and prenatal care ($30,000–$50,000), and insurance for the surrogate and child ($15,000–$30,000).

In Canada, altruistic surrogacy (no compensation above expenses) is legal, with total costs of $60,000–$90,000 including legal fees, medical costs, and expense reimbursements. Ukraine and Georgia offer commercial gestational surrogacy at $40,000–$65,000 total, though geopolitical stability concerns and evolving legal frameworks must be considered carefully. Laos has emerged as an option at $40,000–$70,000, though regulatory frameworks are newer and less established.

In India, the Surrogacy (Regulation) Act 2021 restricts surrogacy to altruistic arrangements involving close relatives (such as a sister or sister-in-law) for Indian citizens and overseas citizens of India (OCI). Commercial surrogacy and surrogacy for foreigners are prohibited. Where Indian altruistic surrogacy is legally available, medical costs are $8,000–$15,000, though finding a willing eligible relative is the primary practical challenge. Intended parents pursuing any international surrogacy arrangement must consult specialized reproductive law attorneys in both countries before proceeding, as laws change frequently and the consequences of non-compliance are severe.

For couples who cannot carry pregnancy due to uterine absence (MRKH syndrome, prior hysterectomy) or severe uterine dysfunction, surrogacy is often the only path to genetically related parenthood. Uterine transplantation is an experimental procedure performed at select centres globally — over 90 live births have been reported, but success rates remain moderate and the procedure carries substantial donor (living or deceased) and recipient risks, with planned hysterectomy after family completion. Adoption provides a non-medically assisted alternative to parenthood, with domestic or international adoption pathways depending on the intended parents' location and circumstances. Child-free living is acknowledged as a valid life choice and should be included in surrogacy counselling alongside all clinical and legal options, recognising the significant emotional and financial burden of the surrogacy journey.